Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the covid era

HIGHLIGHTS

• who: A. Toss from the DepartmentUniversity of Diagnostic Imaging, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy have published the Article: Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era, in the Journal: (JOURNAL) of 12/02/2021
• what: The present analysis aims to evaluate the consequences of a 2-month interruption of mammographic screening on breast cancer (BC) stage at diagnosis and upfront treatments in a region of Northern Italy highly affected by the severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.